Literature DB >> 9187372

DNA fragmentation is a feature of cystic fibrosis epithelial cells: a disease with inappropriate apoptosis?

L Maiuri1, V Raia, G De Marco, S Coletta, G de Ritis, M Londei, S Auricchio.   

Abstract

Cystic fibrosis (CF) is a single-gene disease caused by mutations in the CFTR gene, which result in disrupted chloride secretions with inspissated mucous secretions by exocrine glands. Nick-end labelling was used to assess DNA fragmentation in 14 CF and 24 control duodenal samples, and in two CF and two control lung tissues. In CF small intestine median 46% (range: 30-82) villus enterocytes show DNA fragmentation (vs. 3% (range: 1-7) in controls P < 0.001) and median 37.5% (range: 23-79) crypt enterocytes show Ki67 antigen (P < 0.001). In CF airways 57% (range: 54-70) of epithelial cells show DNA fragmentation. Inappropriate high DNA fragmentation is a feature of various CF epithelia. This could have great impact in understanding the mechanisms leading to disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187372     DOI: 10.1016/s0014-5793(97)00347-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Inhibition of acinar apoptosis occurs during acute pancreatitis in the human homologue DeltaF508 cystic fibrosis mouse.

Authors:  Matthew J DiMagno; Sae-Hong Lee; Chung Owyang; Shi-yi Zhou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-03       Impact factor: 4.052

2.  Intestinal inflammation in cystic fibrosis.

Authors:  R L Smyth; N M Croft; U O'Hea; T G Marshall; A Ferguson
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

3.  Critical role of CFTR-dependent lipid rafts in cigarette smoke-induced lung epithelial injury.

Authors:  Manish Bodas; Taehong Min; Neeraj Vij
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-03-04       Impact factor: 5.464

4.  Fas and Fas ligand expression in cystic fibrosis airway epithelium.

Authors:  I Durieu; C Amsellem; C Paulin; M T Chambe; J Bienvenu; G Bellon; Y Pacheco
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

5.  Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis.

Authors:  R William Vandivier; Valerie A Fadok; Peter R Hoffmann; Donna L Bratton; Churee Penvari; Kevin K Brown; Joseph D Brain; Frank J Accurso; Peter M Henson
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

6.  Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA.

Authors:  Yaqin Xu; Anja Krause; Hiroko Hamai; Ben-Gary Harvey; Tilla S Worgall; Stefan Worgall
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

7.  Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis.

Authors:  Anna Caretti; Alessandra Bragonzi; Marcella Facchini; Ida De Fino; Camilla Riva; Paolo Gasco; Claudia Musicanti; Josefina Casas; Gemma Fabriàs; Riccardo Ghidoni; Paola Signorelli
Journal:  Biochim Biophys Acta       Date:  2013-10-18

8.  FAS engagement drives apoptosis of enterocytes of coeliac patients.

Authors:  L Maiuri; C Ciacci; V Raia; L Vacca; I Ricciardelli; F Raimondi; S Auricchio; S Quaratino; M Londei
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

9.  The calpain, caspase 12, caspase 3 cascade leading to apoptosis is altered in F508del-CFTR expressing cells.

Authors:  Mathieu Kerbiriou; Ling Teng; Nathalie Benz; Pascal Trouvé; Claude Férec
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

10.  Decreasing Poly(ADP-Ribose) Polymerase Activity Restores ΔF508 CFTR Trafficking.

Authors:  Suzana M Anjos; Renaud Robert; Daniel Waller; Dong Lei Zhang; Haouaria Balghi; Heidi M Sampson; Fabiana Ciciriello; Pierre Lesimple; Graeme W Carlile; Julie Goepp; Jie Liao; Pasquale Ferraro; Romeo Phillipe; Françoise Dantzer; John W Hanrahan; David Y Thomas
Journal:  Front Pharmacol       Date:  2012-09-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.